Adam Tomasz Polonek
Corporate Officer/Principal en BIOTON S.A. .
Cargos activos de Adam Tomasz Polonek
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BIOTON S.A. | Corporate Officer/Principal | 20/12/2011 | - |
Director Financiero/CFO | 01/01/2006 | 20/12/2011 | |
M.J. Group
M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Director/Miembro de la Junta | - | - |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Presidente | - | - |
Historial de carrera de Adam Tomasz Polonek
Antiguos cargos conocidos de Adam Tomasz Polonek.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SCIGEN LIMITED | Director/Miembro de la Junta | 28/06/2008 | 07/08/2018 |
Director Financiero/CFO | 01/01/2013 | 31/08/2018 | |
Secretario Corporativo | 01/07/2017 | 07/08/2018 | |
Caib Financial Advisers | Corporate Officer/Principal | 01/01/2000 | 01/01/2006 |
Formación de Adam Tomasz Polonek.
Uniwersytet Ekonomiczny w Katowicach | Undergraduate Degree |
Estadísticas
Internacional
Polonia | 4 |
Singapur | 2 |
Suiza | 2 |
Operativa
Director/Board Member | 2 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOTON S.A. | Health Technology |
Empresas privadas | 4 |
---|---|
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
M.J. Group
M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Health Technology |
Caib Financial Advisers |
- Bolsa de valores
- Insiders
- Adam Tomasz Polonek
- Experiencia